For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

We use cookies to make our site as useful as possible.

Our Cookie Policy explains how you can opt-out of the cookies we use.

If you continue without changing your cookie settings, we'll assume you’re happy with this.

Continue Continue

United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Diagnostic & Therapeutic Solutions
    Custom solutions & partnerships

    Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.

    Create custom solutions with us

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Supporting our customers and employees during the COVID-19 pandemic. Read more

Powering multiplex imaging

Related

  • Review the current approaches for multiplex tissue imaging
    • Explore academic and industry perspectives on multiplex imaging in this panel discussion
      • Oncology's one-biomarker-per-drug paradigm
        • Carrier free antibodies for easier assay development
          • Immuno-oncology antibody panels for IHC
            • Tumor microenvironment and the immune system poster
              • PD-L1, PD1, CD68, CD3, Ki67, panCK Multiplex IHC-IF Antibody Panel
                • New Directions in Immuno-oncology: Response and Resistance conference (February 2021)

                  Get the full picture for your tumor microenvironment research. 

                  Confidently build antibody panels to interrogate the tumor microenvironment in multiplex using an expanding catalog of immuno-oncology focused clones. Our recombinant monoclonal antibodies assure supply and consistency between batches for reproducible results and minimal risk to your panel. Whichever multiplex technique or technology you choose, our recombinant monoclonal rabbit antibodies are available in the right formats to maximize your success.

                  Our dedicated immuno-oncology (IO) team are focused on identifying and prioritizing the most relevant targets in our recombinant monoclonal antibody pipeline. To ensure optimal results for your multiplex imaging experiments, our imaging experts use enhanced immunohistochemical validation procedures, scrutinizing the antibodies in relevant samples and under appropriate conditions, including optimizing panels of antibodies for multiplex IHC-IF (see 6-plex panel here). 

                  Figure 1. Multicolor staining images. A) Multicolor IMC™ image on FFPE tonsil. Image was acquired using the Fluidigm Hyperion™ Imaging System (credit to Goodman Cancer Research Centre, McGill University). B) 7 color IHC-IF multiplex image on FFPE tonsil using 6-plex multiplex IHC-IF panel ab269812 (PD1 [CAL20] ab237728 (orange), PD-L1 [CAL10] ab237726 (green), CD68 [SP251] ab192847 (yellow), CD3 [SP7] ab16669 (red), Ki67 [SP6] ab16667 (light blue), and mouse monoclonal PanCK [C-11] ab7753 (grey) and DAPI nuclear counterstain (dark blue)). Image acquired with a Vectra® Polaris™ Automated Quantitative Pathology Imaging System.

                  ​​For services beyond our catalog, partnerships can be tailored to support the selection and development of the right clones and formats for your experiment. We can collaborate with you to minimize resource spent on finding and trialing suitable clones, enabling you to focus on building your panel. Screen, discover, and innovate faster.


                  Experience the difference

                  ​Daniela Quail is an Assistant Professor at the Goodman Cancer Research Centre at McGill University in Montreal. Her research focuses on the role of the tumor microenvironment (TME) during cancer progression. Using Imaging Mass Cytometry™, Daniela can use about 40 different antibodies on one tissue to get a highly multiplexed image with spatial information to get a comprehensive view of what is going on both in and around a tumor.

                  Daniela Quail, PhD

                  ​​“When we first tried to get this technology off the ground, we needed special formulations and Abcam had recombinant carrier-free antibodies that were ideal because they have a much lower lot-to-lot variability. When we perform IMC™, we want to ensure we can get the exact same quality of antibodies for every experiment, so we don’t have to optimize and validate our antibody batches again and again.

                  Using recombinant antibodies really make sense for scientists investing so much money in antibody-based technologies like IMC™. If we run out of antibody, we don’t want to have to go back to the drawing board and start everything from scratch, it just wastes time. We’ve tested hundreds of antibodies so far and the Abcam carrier-free recombinant antibodies have been the most reliable for us. These antibodies also consistently have a really high percentage of recovery after metal conjugation.”


                  Powering your multiplex research

                  We can offer you the the following features to aid your multiplex imaging experiments:

                  ​​4,000+ IHC-validated standard catalog products

                  • ​​Freedom to select any relevant target to build your panel
                  • Antigen retrieval condition and testing images available on the datasheet

                  Human and mouse species reactivity

                  • ​4,000+ IHC antibodies reactive with human, 2,500+ reactive with mouse

                  Carrier-free, purified format available for all RabMAb® antibodies

                  • ​Designed for use in antibody labelling to achieve higher conjugation efficiency
                  • 1mg/mL concentration

                  Recombinant antibodies

                  • Highest level of consistency between batches and security of long-term supply ​​

                  Bulk orders available

                  • ​Scale up your project with uninterrupted supply of validated antibodies over the length of your study
                    ​

                  Connect with us today at immuno.oncology@abcam.com to discover how we can help accelerate your tumor microenvironment discoveries.​

                  ​

                  Find out more about multiplex technologies​

                  • Overview of multiplex technologies
                  • ​Multiplex imaging: a panel discussion from academic and industry perspectives
                  • ​Exploring the one-biomarker-per-drug paradigm in oncology
                  • Tumor microenvironment and the immune system poster
                  • ​

                  Imaging Mass Cytometry™, Hyperion™  and IMC™ are trademarks of Fluidigm Canada Inc.

                  Vectra® and Polaris™ are trademarks of Akoya Biosciences Inc.

                  “When we first tried to get this technology off the ground, we needed special formulations and Abcam had recombinant carrier-free antibodies that were ideal because they have a much lower lot-to-lot variability. When we perform IMC, we want to ensure we can get the exact same quality of antibodies for every experiment, so we don’t have to optimize and validate our antibody batches again and again.




                  Get resources and offers direct to your inbox Sign up
                  A-Z by research area
                  • Cancer
                  • Cardiovascular
                  • Cell biology
                  • Developmental biology
                  • Epigenetics & Nuclear signaling
                  • Immunology
                  • Metabolism
                  • Microbiology
                  • Neuroscience
                  • Signal transduction
                  • Stem cells
                  A-Z by product type
                  • Primary antibodies
                  • Secondary antibodies
                  • Biochemicals
                  • Isotype controls
                  • Flow cytometry multi-color selector
                  • Kits
                  • Loading controls
                  • Lysates
                  • Peptides
                  • Proteins
                  • Slides
                  • Tags and cell markers
                  • Tools & Reagents
                  Help & support
                  • Support
                  • Make an Inquiry
                  • Protocols & troubleshooting
                  • Placing an order
                  • RabMAb products
                  • Biochemical product FAQs
                  • Training
                  • Browse by Target
                  Company
                  • Corporate site
                  • Investor relations
                  • Company news
                  • Careers
                  • About us
                  • Blog
                  Events
                  • Tradeshows
                  • Conferences
                  International websites
                  • abcam.cn
                  • abcam.co.jp

                  Join with us

                  • LinkedIn
                  • facebook
                  • Twitter
                  • YouTube
                  • Terms of sale
                  • Website terms of use
                  • Cookie policy
                  • Privacy policy
                  • Legal
                  • Modern slavery statement
                  © 1998-2021 Abcam plc. All rights reserved.